Used as an intermediate in the synthesis of anticoagulant drugs, particularly in the development of coumarin-based derivatives that modulate blood clotting. Its structure supports the design of compounds with enhanced metabolic stability and targeted inhibition of vitamin K epoxide reductase. Commonly employed in pharmaceutical research to optimize antithrombotic agents with improved pharmacokinetic profiles.